According to multivariate Cox regression analysis (adjusted for tumor stage, lymph node stage, chemotherapy, and molecular subtype), CCL5 positivity appeared to be an independent poor prognostic factor only for DSS (RR = 1.51; p = 0.047; Table 3). This evidence concerns the gene CCL5 and neoplasm.